Luke Byerly

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “PD-1 Inhibition Enhances Blinatumomab Response in a UCB/PDX Model of Relapsed Pediatric B-Cell Acute Lymphoblastic Leukemia”.

PD-1 Inhibition Enhances Blinatumomab Response in a UCB/PDX Model of Relapsed Pediatric B-Cell Acute Lymphoblastic Leukemia

Frontiers in Oncology(2021)10.3389/fonc.2021.642466

N/A

0DataRank · unranked

28 citations

Nicole Manning, Christina Sexton, Eric O’Brien, Luke Byerly, Cody Stillwell +4 more

PDX models of relapsed pediatric AML preserve global gene expression patterns and reveal therapeutic targets

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.31.478534

N/A

0DataRank · unranked

7 citations

Jing Chen, Christina Sexton, Nicole Manning, Luke Byerly, Eric O’Brien +4 more